A federal courtroom in Lubbock just hit the pause button on one of the biggest fights in vaping regulation. On Oct. 8, 2026, U.S. District Judge James Wesley Hendrix of the Northern District of Texas granted a joint request from the FDA and Altria subsidiaries Helix Innovations and NJOY to stay the lawsuit challenging the agency's 2021 PMTA rule, freezing the case while the FDA pursues anticipated new rulemaking.
The lawsuit, filed Sept. 2, targets the FDA's 2021 premarket tobacco product application framework. Helix Innovations, which markets on! nicotine pouches, and NJOY argue the FDA effectively sidesteps the law's 180-day review clock. The complaint points to nicotine pouch applications that waited more than 2,200 days for decisions, a far cry from the prompt action the statute demands.
A rare moment of agreement
The pause is unusual because both sides asked for it. The FDA announced on Sept. 28 that it intends to reassess and potentially replace the entire PMTA framework. The parties told the court that a new or amended final rule could have a significant effect on the litigation, so fighting over the old framework now would be premature. If the rule at the center of the case is about to change, so could the entire dispute.
Why the FDA wants to hit reset
The agency said it believes "a modern framework that reflects current market realities and provides greater clarity and predictability is critical to maximizing the protection of public health." It gave no timeline and released no draft rule, but said it will keep reviewing applications under the current system while it decides what comes next. The September announcement also acknowledged the Sept. 2 Texas lawsuit, filed in Lubbock by Helix Innovations and NJOY alongside the Texas Food & Fuel Association and two Texas retailers.
The complaint argues the FDA has failed to comply with its obligations under the Family Smoking Prevention and Tobacco Control Act. That law requires the agency to grant or deny new product applications as promptly as possible, and in no event later than 180 days after receipt. But the FDA, the plaintiffs say, has never met this deadline.
Key dates in the case
| Date | What happened |
|---|---|
| Sept. 2, 2026 | Helix Innovations and NJOY filed suit in the Northern District of Texas |
| Sept. 8, 2026 | R.J. Reynolds, Modoral Brands and American Snuff filed a motion to intervene |
| Sept. 28, 2026 | FDA announced plans to reassess and possibly replace the PMTA framework |
| Oct. 8, 2026 | Judge Hendrix granted the joint stay of the lawsuit |
What happens next
The court ordered the parties to file joint status reports within 45 days, and every 45 days after that, keeping the judge posted on the rulemaking's progress. Judge Hendrix granted the stay for the reasons set out by the parties, signaling the court sees the anticipated rulemaking as central to the dispute. Meanwhile, a motion to intervene from R.J. Reynolds (British American Tobacco), Modoral Brands and American Snuff remained pending as of Oct. 9.
For vapers and the industry, the message is clear: the PMTA system that decides which products can legally be sold is up for a rewrite, and the courtroom battles are waiting to see the first draft. To see what has actually cleared the current system so far, check the FDA authorized vapes list.
The stay also lands as Texas continues to tighten its own enforcement, which we break down in our look at Texas vape rules.
Source: 2FIRSTS, October 10, 2026.